Cargando…
RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy
Acute myeloid leukemia (AML) is a rapidly progressing heterogeneous disease with a high mortality rate, which is characterized by hyperproliferation of atypical immature myeloid cells. The number of AML patients is expected to increase in the near future, due to the old-age-associated nature of AML...
Autores principales: | Romanova, Ekaterina I., Zubritskiy, Anatoliy V., Lioznova, Anna V., Ogunleye, Adewale J., Golotin, Vasily A., Guts, Anna A., Lennartsson, Andreas, Demidov, Oleg N., Medvedeva, Yulia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569612/ https://www.ncbi.nlm.nih.gov/pubmed/36232714 http://dx.doi.org/10.3390/ijms231911413 |
Ejemplares similares
-
Genome-wide regulation of CpG methylation by ecCEBPα in acute myeloid leukemia
por: Ogunleye, Adewale J., et al.
Publicado: (2021) -
DNA sequence features in the establishing of H3K27ac
por: Zubritskiy, Anatoliy, et al.
Publicado: (2018) -
Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia
por: Grossmann, V, et al.
Publicado: (2012) -
Clonal haematopoiesis - a novel entity that modifies pathological processes in elderly
por: Belotserkovskaya, Ekaterina, et al.
Publicado: (2023) -
CpG traffic lights are markers of regulatory regions in human genome
por: Lioznova, Anna V., et al.
Publicado: (2019)